Edwards Lifesciences (EW) Stock Forecast & Price Target
EW Analyst Ratings
Strong Buy
10Buy1Hold0Sell
Based on 11 analysts giving stock ratings to Edwards Lifesciences in the past 3 months
EW Stock 12 Month Forecast
Average Price Target
MXN 1,965.65▲(11.83% Upside)Based on 11 Wall Street analysts offering 12 month price targets for Edwards Lifesciences in the last 3 months. The average price target is MXN 1,965.65 with a high forecast of MXN 2,067.13 and a low forecast of MXN 1,597.32. The average price target represents a 11.83% change from the last price of MXN 1,757.67.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 2.07K
AverageMXN 1.97K
LowMXN 1.6K
Highest Price TargetHighestMXN 2,067.13Average Price TargetMXN 1,965.65Lowest Price TargetLowestMXN 1,597.32
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joanne Wuensch | Citi | MXN 1,991.96→MXN 2,067.13 | buy | 17.61%Upside | Reiterated | 11/01/26 | ||
| Josh Jennings | TD Cowen | MXN 1,954.37 | buy | 11.19%Upside | Reiterated | 10/27/26 | ||
| Mike Kratky | Leerink Partners | MXN 1,879.20→MXN 1,898.00 | buy | 7.98%Upside | Reiterated | 10/15/26 | ||
| Marie Thibault | BTIG | MXN 2,067.13 | buy | 17.61%Upside | Reiterated | 10/09/26 | ||
| Christopher Pasquale | Barclays | MXN 2,067.13 | buy | 17.61%Upside | Initiated | 10/07/26 | ||
| Patrick Wood | UBS | MXN 2,067.13 | buy | 17.61%Upside | Reiterated | 10/07/26 | ||
| Kendall Au | RBC Capital | MXN 2,067.13 | buy | 17.61%Upside | Reiterated | 10/01/26 | ||
| Adam Maeder | Piper Sandler | MXN 1,898.00 | buy | 7.98%Upside | Reiterated | 09/21/26 | ||
| Matthew Taylor | Jefferies | MXN 1,973.16 | buy | 12.26%Upside | Reiterated | 09/11/26 | ||
| Brandon Vazquez | William Blair | ― | buy | ― | Reiterated | 09/10/26 | ||
| William Plovanic | Canaccord Genuity | MXN 1,597.32 | hold | -9.12%Downside | Reiterated | 08/03/26 | ||
| Robbie Marcus | J.P. Morgan | MXN 1,973.16 | buy | 12.26%Upside | Reiterated | 07/28/26 | ||
| Richard Newitter | Truist Financial | MXN 1,785.24 | hold | 1.57%Upside | Reiterated | 07/24/26 | ||
| Suraj Kalia | Oppenheimer | ― | hold | ― | Reiterated | 07/24/26 | ||
| Rick Wise | Stifel Nicolaus | MXN 2,067.13 | buy | 17.61%Upside | Reiterated | 07/24/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joanne Wuensch | 11/01/26 | MXN 1,991.96→MXN 2,067.13 | buy | 17.61%Upside | Reiterated | Citi | ||
| Josh Jennings | 10/27/26 | MXN 1,954.37 | buy | 11.19%Upside | Reiterated | TD Cowen | ||
| Mike Kratky | 10/15/26 | MXN 1,879.20→MXN 1,898.00 | buy | 7.98%Upside | Reiterated | Leerink Partners | ||
| Marie Thibault | 10/09/26 | MXN 2,067.13 | buy | 17.61%Upside | Reiterated | BTIG | ||
| Christopher Pasquale | 10/07/26 | MXN 2,067.13 | buy | 17.61%Upside | Initiated | Barclays | ||
| Patrick Wood | 10/07/26 | MXN 2,067.13 | buy | 17.61%Upside | Reiterated | UBS | ||
| Kendall Au | 10/01/26 | MXN 2,067.13 | buy | 17.61%Upside | Reiterated | RBC Capital | ||
| Adam Maeder | 09/21/26 | MXN 1,898.00 | buy | 7.98%Upside | Reiterated | Piper Sandler | ||
| Matthew Taylor | 09/11/26 | MXN 1,973.16 | buy | 12.26%Upside | Reiterated | Jefferies | ||
| Brandon Vazquez | 09/10/26 | ― | buy | ― | Reiterated | William Blair | ||
| William Plovanic | 08/03/26 | MXN 1,597.32 | hold | -9.12%Downside | Reiterated | Canaccord Genuity | ||
| Robbie Marcus | 07/28/26 | MXN 1,973.16 | buy | 12.26%Upside | Reiterated | J.P. Morgan | ||
| Richard Newitter | 07/24/26 | MXN 1,785.24 | hold | 1.57%Upside | Reiterated | Truist Financial | ||
| Suraj Kalia | 07/24/26 | ― | hold | ― | Reiterated | Oppenheimer | ||
| Rick Wise | 07/24/26 | MXN 2,067.13 | buy | 17.61%Upside | Reiterated | Stifel Nicolaus |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Edwards Lifesciences
3 Months
Success Rate19/29 ratings generated profit
66%
Average Return
+1.62%
Copying Adam Maeder's trades and holding each position for 3 Months would result in 65.52% of your transactions generating a profit, with an average return of +1.62% per trade.
1 Year
Success Rate11/13 ratings generated profit
85%
Average Return
+3.82%
Copying Travis Steed's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +3.82% per trade.
2 Years
Success Rate11/13 ratings generated profit
85%
Average Return
+6.85%
Copying Travis Steed's trades and holding each position for 2 Years would result in 84.62% of your transactions generating a profit, with an average return of +6.85% per trade.
EW Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 39 | 34 | 25 | 17 | 16 |
| Hold | 6 | 7 | 5 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 45 | 41 | 30 | 18 | 16 |
In the current month, EW has received 16 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EW average Analyst price target in the past 3 months is 1,965.65.
EW Financial Forecast
HighMXN 14.47
ConsensusMXN 13.85
LowMXN 13.53
EW Earnings Forecast
Next quarter’s earnings estimate for EW is MXN 13.85 with a range of MXN 13.53 to MXN 14.47. The previous quarter’s EPS was MXN 14.66. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 32.1B
ConsensusMXN 31.5B
LowMXN 31B
EW Sales Forecast
Next quarter’s sales forecast for EW is MXN 31.51B with a range of MXN 31.01B to MXN 32.06B. The previous quarter’s sales results were MXN 32.72B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
EW Stock Forecast FAQ
What is MX:EW’s average 12-month price target, according to analysts?
Based on analyst ratings, Edwards Lifesciences’s 12-month average price target is Mex$1,965.65.
What is MX:EW’s upside potential, based on the analysts’ average price target?
Edwards Lifesciences has 11.83% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Edwards Lifesciences a Buy, Sell or Hold?
Edwards Lifesciences has a consensus rating of Strong Buy, which is based on 10 buy ratings, 1 hold ratings and 0 sell ratings.
What is Edwards Lifesciences’s share price target?
The average share price target for Edwards Lifesciences is Mex$1,965.65. This is based on 11 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$2,067.13, and the lowest forecast is Mex$1,597.32. The average share price target represents a 11.83% increase from the current price of Mex$1,757.67.
What do analysts say about Edwards Lifesciences?
Edwards Lifesciences’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Street analysts.
How can I buy shares of Edwards Lifesciences?
To buy shares of MX:EW, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
